K’taka COVID-19 update: 1704 new cases, 1537 discharges, 13 deaths on Nov 21
Team Udayavani, Nov 22, 2020, 8:51 PM IST
Bengaluru: On November 21, 1,704 new cases of COVID-19 were reported from across the State along with 1,537 recoveries and 13 COVID-19 deaths.
The total number of COVID-19 cases in the State now stands at 8,73,046 out of which 24,868 cases are presently active and 11,654 dead.
Bengaluru Urban district reported 1,039 COVID-19 cases, the highest in the State on the same day.
Mysuru district reported 100 COVID-19 cases while all the other districts reported less than 100 cases.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
India beat Australia by 11 runs in first T20 International
SC sends notice to K’taka govt over Ragini’s bail plea in drugs case
K’taka: Expert panel recommends banning New Year public celebrations
Related Articles More
Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy
COVID-19 caseload in India rises to 95.71 lakh with 36,595 new infections
K’taka COVID-19 update: 1446 new cases, 894 discharges, 13 dead on Dec 2
5 Covid-19 Vaccines Undergoing Trial in India Logistically Feasible for Distribution in Both Urban, Rural Areas: AIIMS Director
Committed to engaging with Indian govt to make vaccine available in country: Pfizer
Without sulking from his illness, this young man changed his life through agriculture
State government must immediately bring in anti-cow slaughter law: Sri Vishwa Prasanna Tirtha Swamiji
Hamsa Chaitanya Desi Outlet | Desi Products Store Udupi | Documentary by Udayavani
Pro-terror graffiti case culprits will be arrested soon: Basavaraj Bommai
Meal of Bakasur : Hotel Fish Campus Udupi | Udayavani
Anil Kapoor refutes reports of testing positive for COVID-19
PNB Scam: No Bail for Top Official of Mehul Choksi’s Firm
Former IB Director and J&K Interlocutor Dineshwar Sharma Passes Away at 66 Due to Lung Ailment
ADB approves $190 mn loan to upgrade Bengaluru’s power distribution system
COVID-19 vaccine should be kept affordable, free of cost for economically vulnerable: Deve Gowda